Wolverine Asset Management’s LAVA Medtech Acquisition Corp. Class A Common Stock LVAC Stock Holding History

Wolverine Asset Management’s Portfolio LVAC Stock Details LVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-215,389	Closed	-$2.25M	–	2048
2023 Q1	$2.25M	Sell	215,389 -5,391	-2%	-$55.8K	0.03%	488
2022 Q4	$2.27M	Sell	220,780 -7,115	-3%	-$72K	0.02%	532
2022 Q3	$2.29M	Buy	227,895 +388	+0.2%	+$3.89K	0.02%	518
2022 Q2	$2.27M	Sell	227,507 -2,915	-1%	-$29.1K	0.02%	518
2022 Q1	$2.3M	Sell	230,422 -78,978	-26%	-$784K	0.02%	471
2021 Q4	$3.05M	Buy	+309,400	New	+$3.06M	0.03%	436

Wolverine Asset Management's LVAC Position: Q2 2023 in Review

Wolverine Asset Management sold out of LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) in Q2 2023, closing a stake of 215,389 shares — an estimated $2.25M sold.

Wolverine Asset Management first reported a position in LVAC in Q4 2021 and held it in 6 quarters. The position peaked at $3.05M in Q4 2021. 0 funds tracked by Wall St. Rank hold LVAC as of Q2 2023.

Wolverine Asset Management reported no remaining LAVA Medtech Acquisition Corp. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
Wolverine Asset Management sold 215,389 LAVA Medtech Acquisition Corp. Class A Common Stock shares in Q2 2023, an estimated $2.25M.
Wolverine Asset Management first reported a position in LAVA Medtech Acquisition Corp. Class A Common Stock in Q4 2021 and held it in 6 quarters.
Wolverine Asset Management's LAVA Medtech Acquisition Corp. Class A Common Stock position peaked at $3.05M in Q4 2021.
0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Class A Common Stock as of Q2 2023.

Based on Wolverine Asset Management's 13F filing for Q2 2023, filed 7 Aug 2023.